Randomized trial to assess oxytocin and vibration's impact on UV-B burn heat pain

Acute pain from UV-B burns is a common issue, often managed with topical analgesics or NSAIDs, which may offer incomplete relief or have side effects. There's a growing interest in non-opioid pain management strategies, particularly those leveraging endogenous neurohormones. Oxytocin, known for its roles in social bonding and stress reduction, also exhibits analgesic properties in various pain models, potentially via central and peripheral oxytocin receptors. The precise mechanisms and clinical utility of oxytocin in acute inflammatory pain, especially when combined with non-pharmacological interventions like vibration, remain underexplored. This trial aims to bridge that gap by examining oxytocin's effect on thermal pain thresholds in sunburned skin.

This randomized controlled trial is designed to evaluate the effects of intravenous oxytocin and vibration on heat pain threshold. Participants will receive a mild UV-B burn on an area of skin. The intervention involves administering oxytocin intravenously, likely at a specific dose (though not explicitly stated in the provided abstract snippet), in conjunction with localized vibration. The primary endpoint is the Verbal Pain Score measured at one-minute intervals during a five-minute skin heating period. These measurements will be taken at intervals up to 180 minutes post-infusion, and then again at 24 hours and 5-7 days. The study design includes a comparator arm, implied by the "randomized controlled trial" designation, likely involving placebo or vibration-only conditions, to isolate the effects of oxytocin and vibration.

This record describes the design and objectives of a randomized controlled trial, rather than presenting completed results. The core finding of this design is the establishment of a robust protocol to investigate the analgesic potential of oxytocin in UV-B burn-induced thermal pain. The study is specifically designed to determine if intravenous oxytocin can increase the heat pain threshold in sunburned skin, and whether the presence of vibration modulates this effect. This detailed time-course assessment aims to provide insights into the onset, duration, and potential synergy of oxytocin's pain-modulating actions. The design also implicitly acknowledges the complexity of pain perception, incorporating both pharmacological and physical interventions. > The trial's primary objective is to quantify changes in Verbal Pain Score during a 5-minute skin heating period, measured at multiple time points: up to 180 minutes after oxytocin infusion, and again at 24 hours and 5-7 days.